Growth, Innovation, and Strategy
The convergence of life sciences and technology continues to have a tremendous impact across the life sciences industry. Innovation is moving at a rapid pace, investment across the sector is at an all-time high, and companies are adopting new business models in response to the ongoing pandemic.
Morrison & Foerster welcomed 100+ attendees for our virtual Life Sciences MoForum to discuss the business, legal, and regulatory trends that are driving innovation and growth in the life sciences today.
We hosted a series of three programs featuring leading life sciences innovators to discuss the key strategies shaping the industry today and what to expect in 2022. We concluded with a fireside chat with Shannon Klinger, chief legal officer of Moderna, who shared her unique perspective on the industry’s response to the pandemic and her outlook for the future.
Tuesday, January 25, 2022
Digital Transformation in the Life Sciences
Moderated by: Brigid Bondoc, of counsel, FDA Regulatory and Compliance practice
Speakers include:
Wednesday, January 26, 2022
The Future of Drug Discovery and Diagnostics
Moderated by: Matthew Karlyn, partner, Life Sciences Transactions & Licensing practice
Speakers include:
Thursday, January 27, 2022
Fireside Chat with Shannon Klinger, Chief Legal Officer, Moderna
Moderated by: Deanne Maynard, partner and co-chair Appellate and Supreme Court practice
Disclaimer
Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.
